Dr. Éva Leiter received a HIF Conference Support Scholarship to attend and present at the Drug Discovery and Therapy World Congress held in Boston, Massachusetts this past summer.
The Drug Discovery and Therapy World Congress brings together some of the best and brightest Pharmaceutical Scientists, Doctors, and CEOs in the field. The 2017 conference was held in Boston, Massachusetts and attracted professionals from over 30 countries. The conference also featured a number of Nobel Laureates, who shared their recent research and breakthroughs in drug discovery. HIF is proud to have sponsored Dr. Éva Leiter, who was able to present her own work at the conference and is making a strong impact in the field.
Dr. Leiter is a Senior Lecturer in the Department of Biotechnology and Microbiology at the University of Debrecen in Hungary. Her presentation covered how the Penicillium Chrysogenum Antifungal Protein (PAF) can be a promising antimycotic (antifungal) candidate in the treatment of invasive pulmonary aspergillosis (IPA). IPA is a disease where mold begins to fester in the lungs and can then affect other organs and tissues in the body. It is generally seen in patients whose immune systems have been weakened or compromised. Dr. Leiter’s presentation added to the growing discussion on the topic and will allow her to better collaborate with her colleagues on future projects.
“Attending the conference gave me a great chance to meet scientists interested in the research field of small antimicrobial proteins as well as drug delivery systems for future collaboration and grant application. Moreover, because I also take part in Bachelor of Science and Master of Science educational programs at the University of Debrecen, the conference attendance helped me to become up to date on relevant curricula in the fields of drug discovery.”
Beyond her presentation, the conference also provided an effective platform for Dr. Leiter to grow her professional network. She was able to hear other scholars present their ideas in coming to a consensus on the next step for their field. Thus, the conference provided a solid foundation for Dr. Leiter’s groundbreaking work moving forward.
“The conference gave me a great opportunity to listen to presentations (including the lecture by Nobel Laureate Dr. Ferid Murad) about the latest scientific results and developments of drug discovery, including the small molecular mass antimicrobial proteins, and to discuss questions concerning the drug discovery and therapy with researchers from all over the world. I would like to thank the Hungary Initiatives Foundation for the support.”